(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

OXABICICLO-HEPTANOS PARA MODULAÇÃO DA RESPOSTA IMUNOLÓGICA

Em ExigênciaInvention PatentPCT · US2017065270

Application data

Number

112019011627

Type

Invention Patent

Filing

12/08/2017

Publication

11/12/2019

PCT

US2017065270

Progress at the INPI

Technical opinion to answer
  1. Filing12/08/17
  2. Publication11/12/19
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 10/13/2021. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

LIXTE BIOTECHNOLOGY, INC.

US

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

US

Inventors

H. W. (pessoa física)

US

J. K. (pessoa física)

US

R. L. (pessoa física)

US

S. H. (pessoa física)

US

Z. Z. (pessoa física)

US

Technical data

Priority claims

US

62/465,001 · 02/28/2017

US

62/497,949 · 12/08/2016

US

62/545,373 · 08/14/2017

Abstract

A presente invenção refere-se a um método para tratar um indivíduo que sofre de câncer compreendendo administrar ao indivíduo uma quantidade eficaz de um inibidor de PP2A.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Adição na publicação

#15.35

10/13/2021

RPI 2649

Parecer de pré-exame

#6.23

10/13/2021

RPI 2649

Notificação de entrada na fase nacional - PCT

#1.3

11/12/2019

RPI 2549

Alteração de dados cadastrais

#1.1

06/25/2019

RPI 2529

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.